ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
90.43
+0.20 (0.22%)
At close: Nov 7, 2025, 4:00 PM EST
91.35
+0.92 (1.02%)
After-hours: Nov 7, 2025, 5:35 PM EST
ANI Pharmaceuticals Market Cap
ANI Pharmaceuticals has a market cap or net worth of $1.89 billion as of November 7, 2025. Its market cap has increased by 52.17% in one year.
Market Cap
1.89B
Enterprise Value
2.25B
1-Year Change
52.17%
Ranking
Category
Stock Price
$90.43
Market Cap Chart
Since May 5, 2000, ANI Pharmaceuticals's market cap has increased from $31.10M to $1.89B, an increase of 5,978.34%. That is a compound annual growth rate of 17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 2.03B | 74.79% |
| Dec 31, 2024 | 1.16B | 3.16% |
| Dec 29, 2023 | 1.13B | 60.39% |
| Dec 30, 2022 | 702.60M | 19.57% |
| Dec 31, 2021 | 587.60M | 63.72% |
| Dec 31, 2020 | 358.90M | -51.87% |
| Dec 31, 2019 | 745.70M | 39.70% |
| Dec 31, 2018 | 533.80M | -28.93% |
| Dec 29, 2017 | 751.10M | 6.89% |
| Dec 30, 2016 | 702.70M | 35.42% |
| Dec 31, 2015 | 518.90M | -18.78% |
| Dec 31, 2014 | 638.90M | 235.20% |
| Dec 31, 2013 | 190.60M | 533.22% |
| Dec 31, 2012 | 30.10M | -45.47% |
| Dec 30, 2011 | 55.20M | -52.74% |
| Dec 31, 2010 | 116.80M | 50.13% |
| Dec 31, 2009 | 77.80M | 183.94% |
| Dec 31, 2008 | 27.40M | -73.32% |
| Dec 31, 2007 | 102.70M | 58.73% |
| Dec 29, 2006 | 64.70M | -8.62% |
| Dec 30, 2005 | 70.80M | -29.83% |
| Dec 31, 2004 | 100.90M | 79.86% |
| Dec 31, 2003 | 56.10M | 95.47% |
| Dec 31, 2002 | 28.70M | -46.55% |
| Dec 31, 2001 | 53.70M | 72.12% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |